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CRP was increased in 75.3%. A cardiac MRI was performed in 90.5% of
cases and a coronary angiography in 47.6% of cases. No endomyocardial
biopsy was performed. An infectious aetiology was found in 47.6% of cases.
Treatment included aspirin (87.5%), beta-blockers (66.5%), and ACE inhibi-
tors (42.9%). There was no death during hospital stay. At a mean follow-up
of 28±20 months, 2 Pts (2.6%) died from non-cardiac causes and recurrences
occurred in only 5.3% of Pts. Mean ejection fraction was 62.1±5.3%.
Conclusion Patients admitted in a cardiology intensive care unit for acute
myocarditis are mostly young males and a large part of admissions occurs
during winter. In-hospital and mid-term outcome is good.
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Thrombolytic therapy (TT) has a beneficial risk to benefit ratio for patients
presenting with massive pulmonary embolism (PE). The PEITHO study sug-
gested that patients with sub massive PE may improve their hemodynamic
status and prognosis after TT but with an excess of haemorrhagic complica-
tions (HC). Elderly patients are also more likely to experience sever HC and
it has been suggested that half doses TT may be indicated in this population.
TT indication remains questionable in these borderline patients.
To investigate incidence and predictors of major HC in our population we
performed a retrospective analysis of all PE patients treated with TT in the
Cardiac Intensive Care Unit of our university hospital from 1992 to 2014. 
From February 1992 to December 2014, 293 PE patients received TT.
Among them 35 experienced severe HC following the PEITHO study defini-
tion. 23 (8%) patients died during the acute phase, 7 from HC and 16 from
haemodynamic complications.
Although before 1996 TT was frequently administered in sub massive PE and
elderly patients we didn’t observed a significantly higher rate of severe HC in the
1992-1996 period. Bleeders were not significantly older than non-bleeders (72 vs
67, p=0,09) and were more likely to receive alteplase as TT (p=0,045). Severe HC
were significantly more frequent in patients presenting with syncope (37% vs
15%, p=0,0064) or shock (66% vs 36%, p=0,0006). Patients with severe HC had
a significantly higher death rate during hospitalisation (23% vs 6%, p=0,0005).
From our observational data we derived the HACASSP score that robustly pre-
dicts severe haemorrhagic complications in our population combining hyperten-
sion, age>75, cancer, anemia, shock, sex, platelet count (C statistic=0.73).
Our analysis suggests that it may be possible to predict high risk of severe hae-
morrhagic complications of TT in PE patients and therefore to improve the risk to
benefit ratio of TT especially in patients with sub massive PE at presentation.
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Background Identification of the coronary origin of a thoracic pain by the
emergency physician in charge of telephone triage at the pre-hospital emer-
gency service is a key element of prognosis. 
Purpose To build a gender-specific telephone score for predicting ACS for
patients calling for non-traumatic thoracic pain. 
Method Observational multicenter prospective study. Patients
≥18 years old calling the telephone triage center for a non-traumatic chest
pain were included. The outcome was ACS diagnosis estimated by two
independent experts. Separate models were built for men and women.
Multivariable analyses were carried out to identify predictive items of
ACS using a stepwise logistic regression. Models performances were
assessed (c-statistic). Data were randomly divided into a derivation and a
validation sample. 
Results In three medical centers, 3727 patients were included (2097 men,
1630 women). ACS were diagnosed in 24.2% of men and 8.5% of women.
Among men, variables independently associated with ACS were age,
smoking, pain intensity, persistence of pain, retrosternal pain, lack of
increased intensity with inspiration, pain irradiations, pain association to other
signs. The area under the receiver operator characteristic (ROC) curve (AUC)
was 0.76 (95% confidence interval (CI) 0.73-0.79). A 48 point score was built.
The AUC of the score applied to the validation sample was 0.77 (95% CI
0.73-0.80). Among women, variables independently associated with ACS
were age, previous coronary artery disease, lack of increased pain intensity
with inspiration, pain irradiations. The AUC was 0.79 (0.75-0.83). A 23 point
score was built. The AUC of the score applied to the validation sample was
0.67 (95% CI 0.60-0.74). 
Conclusion Predictive characteristics of ACS in patients who call medical
dispatch centre for chest pain are different for women and men. The predictive
accuracy of the models we developed was better among men than women. 
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Background Acute chest pains without troponin raise are challenging in
patients with pre-existing coronary artery disease (CAD). 
Purpose To evaluate the diagnostic and incremental prognostic values of
copeptin in patients with normal high sensitivity troponin T (hs-cTnT) value,
pre-existing CAD and acute chest pain. 
Methods This monocentric prospective study included 91 consecutive
patients with documented CAD admitted in the intensive care units for
chest pain lasting for less than ten hours. Acute coronary syndrome (ACS)
was excluded with ECG and hs-cTnT values <14ng/L at baseline and with
dynamic changes ≤50% three hours later and <20% if baseline hs-cTnT
between 14 and 50ng/L (Roche Diagnostics, COBAS 8000). The hs-cTnT
assay was validated with the upper reference limit (99th percentile) of
14ng/L and limit of detection at 5ng/L. Blood samples for determination
of copeptin (Thermofisher, Kryptor Compact) were collected at pre-
sentation. Copeptin value was considered as positive when >10pmol/L
(detection limit at 2pmol/L). Prognosis evaluation concerned absence of
severe stenosis (>90%) or fractional flow reserve >0.80 at coronary angi-
ography, or absence of myocardial ischemia induced with nuclear stress
imaging. 
Results Mean age of patients was 58±8,72 (79.3%) were male. The mean
time between chest pain onset and blood samples was 4±2 hours. According
to clinical decision, coronary angiography was performed in 63 patients
(69.2%), with 12 severe stenosis diagnosed (19%). No ischemia was detected
with the stress tests (28 patients). Among the 52 patients with a negative
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kinetic of hs-cTnT and a negative copeptin, only 2 (3.8%) had a critical ste-
nosis (NPV 95%) both related to in stent restenosis (table 1). 
Conclusion In patients with pre-existing CAD, once ACS is excluded,
copeptin provides a useful additional triage strategy in acute chest pain to
exclude severe coronary stenosis or stenosis inducing myocardial
ischemia.
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Background In submassive pulmonary embolism (PE), when a right ven-
tricular (RV) dysfunction (RVD) is present, the benefit of fluid expansion
(FE) is questionable. The Franck-Starling law suggests that the reduction of
the RV overload may enhances the RV systolic function. 
Purpose The aim of our study was to compare the effects of a diuretic
treatment (DT) versus FE in patients hospitalized for normotensive PE with
RVD. 
Methods We performed a prospective study. Consecutive patients hospi-
talized for normotensive PE were treated with diuretic (40mg IV furosemide
at admission) or FE (500cc of sodium chloride infusion during four hours at
admission). The primary endpoint was the timing for normalization of BNP
and troponin Ic values. The secondary endpoints were variations of clinical
and RV echographic parameters. 
Results Forty five patients were included. Timing for Troponin and BNP
normalization was 60,7±28 hours in the DT versus 93,2±42 hours in the FE
group (figure 1, p=0.02). Normalization of RV dilatation took 91,7±14,2 hours
in the DT group versus 108,4±17,5 hours in the FE group (p=0.01). Norma-
lization of the RVD took 81,2±18 hours in the DT group versus 94,9±13,1
hours in the FE group (p=0.03). 
Conclusion In the early management of normotensive PE with RVD, DT
may be superior to FE in order to improve the time to normalization of
biological and echocardiographic markers.
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Abstratct 0291 – Table: Predictive values 
 Sensitivity Specificity Positive predictive value Negative predictive value
 hs-cTnT <14 ng/L and <50% 
change at 3 hours
n=91
0.22
IC (0.028-0.6)
0.73
IC(0.604-0.83)
0.10
IC(0.012-0.317)
0.87
IC (0.755-0.947)
Copeptin <10 pmol/L + hs-
cTnT <14 ng/L
n=71
0.75
IC(0.428-0.945)
0.6
IC (0.476-0.715)
0.24
IC(0.118-0.412)
0.93
IC(0.817-0.986)
Copeptin<10 pmol/L + negative 
kinetic of hs-cTnT at 3 hours
n=52
0.79
IC (0.4-0.972)
0.54
IC (0.418-0.669)
0.19
IC (0.08-0.352)
0.95
IC (0.823-0.994)
Abstract 0358 – Figure 1
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